## BACKGROUND. Prostate cancer, like other solid tumors, is a rather heterogeneous entity. More than 50% of all malignant prostatic tumors contain neuroendocrine-like cells, which cannot be attributed to small cell prostatic carcinoma or carcinoid-like tumors, which represent only 1-2% of all prost
Neuroendocrine differentiation in prostatic adenocarcinoma and its relationship to tumor progression
β Scribed by Michael K. Cohen; Daniel A. Arber; K. Scott Coffield; Gerald T. Keegan; Joseph McClintock; V. O. Speights Jr.
- Publisher
- John Wiley and Sons
- Year
- 1994
- Tongue
- English
- Weight
- 582 KB
- Volume
- 74
- Category
- Article
- ISSN
- 0008-543X
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
## Abstract The LNCaP cell line is a versatile and useful model suitable for the study of human prostate cancer in vitro. It has been determined that the elevation of LNCaP intracellular cyclic adenosine monophosphate (cAMP) levels through the addition of membraneβpermeable cAMP analogs, phosphodie
## Background: Although, in general, immunoperoxidase staining for prostate-specific antigen (psa) and prostate-specific acid phosphatase (psap) cannot distinguish between benign and malignant prostatic epithelium, immunoreactivity of these antigens may be helpful in predicting prognosis of prostat